Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
Urinary Bladder01:23

Urinary Bladder

The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Physiology of the Genitourinary System III: Urine Concentration and Dilution01:20

Physiology of the Genitourinary System III: Urine Concentration and Dilution

The kidneys concentrate or dilute urine to maintain water and electrolyte balance. Nephrons, particularly the loop of Henle, play a crucial role in this process through the countercurrent multiplication system. This system establishes a high osmolarity in the renal medulla, which is essential for water reabsorption. In the loop of Henle’s descending limb, water is reabsorbed into the surrounding medulla due to its permeability to water. In contrast, the ascending limb actively transports...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptive Pudendal Nerve Stimulation: A Pilot Study on Safety, Technical Feasibility, and Clinical Effect.

Neurourology and urodynamics·2026
Same author

Comment on "Low-Energy Shockwave Therapy for Interstitial Cystitis/Bladder Pain Syndrome From Bench to Clinic" by Chia-Hung Tsai, Yuan-Chi Shen, Hung-Jen Wang, Wei-Chia Lee, Cheng-Yen Kao and Yao-Chi Chuang.

International journal of urology : official journal of the Japanese Urological Association·2026
Same author

Editorial Comment on "Gynecologic Manifestations of Interstitial Cystitis/Bladder Pain Syndrome" by K. E. Whitmore and J. Pires.

International journal of urology : official journal of the Japanese Urological Association·2026
Same author

Urethral Sensory Receptors in Voiding Physiology and Lower Urinary Tract Symptoms.

European urology focus·2026
Same author

Perioperative and clinical outcomes in patients undergoing Retzius-sparing robot assisted radical prostatectomy stratified by the degree of obesity.

International urology and nephrology·2026
Same author

Outcomes of Retzius-sparing robot-assisted radical prostatectomy in men aged ≥ 75 years.

BMC urology·2026
Same journal

Monoclonal antibodies for treatment of osteoporosis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Mitapivat for sickle cell disease and thalassemia.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Cenegermin for the treatment of dry eye disease.

Drugs of today (Barcelona, Spain : 1998)·2023
See all related articles

Related Experiment Video

Updated: Jul 4, 2026

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

Urgency in overactive bladder: translating experimental data into clinical practice.

Jean-Jacques Wyndaele1, Stefan De Wachter

  • 1Urology, Faculty of Medicine and University Hospital Antwerp, University Antwerp, Belgium. Jean-Jacques.Wyndaele@uza.be

Drugs of Today (Barcelona, Spain : 1998)
|June 13, 2008
PubMed
Summary
This summary is machine-generated.

Overactive bladder (OAB) syndrome is characterized by urgency, a sudden compelling need to urinate. Antimuscarinic agents like oxybutynin and solifenacin are effective but require further clinical trials for optimal OAB management.

Related Experiment Videos

Last Updated: Jul 4, 2026

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Overactive bladder (OAB) syndrome's primary symptom is urgency, a sudden, compelling desire to urinate.
  • The definition of urgency is debated, but it significantly impacts OAB diagnosis and treatment evaluation.

Purpose of the Study:

  • To review the pharmacological approaches to managing urgency in OAB syndrome.
  • To discuss the efficacy and limitations of current treatments, particularly antimuscarinic agents.

Main Methods:

  • Review of existing literature on OAB pathophysiology and pharmacological interventions.
  • Analysis of clinical trial data for antimuscarinic drugs used in OAB treatment.

Main Results:

  • Antimuscarinic agents (oxybutynin, tolterodine, darifenacin, solifenacin, trospium) demonstrate superiority over placebo in managing OAB symptoms.
  • These drugs exhibit varying side effect profiles.

Conclusions:

  • Antimuscarinic agents are a cornerstone in OAB management, targeting urgency effectively.
  • Further large-scale, randomized controlled trials are needed to solidify their role and optimize treatment strategies for urgency and OAB syndrome.